Author： García-Marcos L.
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.26, Iss.7, 2003-01, pp. : 483-518
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A Risk-Benefit Assessment of Antileukotrienes in Asthma
By Smith L.J.
Drug Safety, Vol. 19, Iss. 3, 1998-09 ,pp. :
Access to resources
Recommend
A Benefit-Risk Assessment of Sibutramine in the Management of Obesity
Drug Safety, Vol. 26, Iss. 14, 2003-01 ,pp. :
Benefit-Risk Assessment of Ropivacaine in the Management of Postoperative Pain
By Wolfgang Zink Bernhard M. Graf
Drug Safety, Vol. 27, Iss. 14, 2004-01 ,pp. :
Benefit-Risk Assessment of Irinotecan in Advanced Colorectal Cancer
Drug Safety, Vol. 28, Iss. 5, 2005-01 ,pp. :
A Preliminary Benefit-Risk Assessment of Varenicline in Smoking Cessation
By Cahill Kate Stead Lindsay Lancaster Tim
Drug Safety, Vol. 32, Iss. 2, 2009-01 ,pp. :